Skip to main content

Cassandra L. Paolillo

Associate

[email protected]

+1.617.348.1828

Share:

Cassie’s practice primarily involves advising health care clients on transactional and regulatory matters, including mergers and acquisitions, regulatory compliance, and general contracting.

Throughout her career, Cassie has worked with providers, payors, and individual patients, so she understands the unique challenges facing clients in the ever-changing health care landscape.

Prior to joining Mintz, Cassie worked as in-house counsel at a national senior living company. There she advised the business on matters related to state and federal health care regulations, physician arrangements, reimbursement, fraud and abuse, and HIPAA/privacy. She also oversaw all contracting matters for the company’s skilled nursing division.

Cassie’s in-house experience informs current her practice, enabling her to anticipate and relate to clients’ legal and business needs.

During her time at Suffolk University Law School, Cassie had the privilege of representing indigent clients before the Social Security Administration and Suffolk Probate Court as a student attorney with the school’s Health Law Clinic. She also served as Editor-in-Chief of Suffolk’s Journal of Health & Biomedical Law.

Education

  • Suffolk University Law School (JD, summa cum laude)
  • Boston College (BA, cum laude)

Involvement

  • Member, American Health Lawyers Association
  • Member, Boston Bar Association

Viewpoints

Viewpoint

HPC Weighs in on Impact of Question 1

November 1, 2018| Advisory

This article discusses a Massachusetts Health Policy Commission report on the impact of Questions 1, the proposed Nurse Staffing Ratio Mandate.
Viewpoint
The Massachusetts Health Policy Commission (“HPC”) held its annual Health Care Cost Trends Hearing on October 16-17, 2018. The hearing covered a wide range of topics affecting the health care industry here in the Commonwealth and across the country. Here are some key takeaways and a legislative outlook.
Viewpoint
The final bipartisan opioid package, which passed in the Senate this week and is expected to be signed into law, includes a significant revision from the original House bill that could lead to an increase in treatment options for Medicaid beneficiaries suffering from substance use disorder (“SUD”). The final version of the “SUPPORT for Patients and Communities Act” will provide state Medicaid programs with the option to cover SUD treatment in certain Institutions for Mental Diseases (“IMD”) for Medicaid beneficiaries between the ages of 21 and 64.
The Children’s Health Insurance Program (“CHIP”), created in 1997, helps states provide health care coverage to low-income children up to age 19 whose families fall above the Medicaid eligibility threshold but are unable to afford private insurance.
The Centers for Medicare & Medicaid Services (CMS) recently released its final rule overhauling long-term care (LTC) facility participation requirements for Medicare and Medicaid (“Final Rule”).